source
- Compass Pathways CEO says company will proceed cautiously as it readies psychedelic therapy for FDA reviewCompass Pathways chief executive Kabir Nath told reporters at the STAT Summit that the company will "go slow before we go fast," emphasizing that early negative experiences could hurt the emerging…
- Former FDA commissioners slam current HHS leadership over research cuts and regulatory challengesFormer FDA commissioners Rob Califf, Scott Gottlieb and Ned Sharpless publicly criticized the officials running the agency, saying the current HHS leadership is failing the FDA. They highlighted m…